Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
Autor: | Keegan SP, Gallagher EM, Ernst NE, Young EJ, Mueller EW, Keegan, Shaun P, Gallagher, Erika M, Ernst, Neil E, Young, Emily J, Mueller, Eric W |
---|---|
Zdroj: | Annals of Pharmacotherapy; Jan2009, Vol. 43 Issue 1, p19-27, 9p |
Databáze: | Supplemental Index |
Externí odkaz: |